Belite Bio, Inc (BLTE) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-03 06:12:12 ET
Belite Bio, Inc (BLTE) Q4 2025 Earnings Call March 2, 2026 4:30 PM EST
Company Participants
Hao-Yuan Chuang - CFO & Director
Yu-Hsin Lin - Chairman of the Board of Directors & CEO
Hendrik Scholl - Chief Medical Officer
Nathan L. Mata - Chief Scientific Officer
...
Read the full article on Seeking Alpha
For further details see:
Belite Bio, Inc (BLTE) Q4 2025 Earnings Call Transcript
Belite Bio Inc
NASDAQ: BLTE
BLTE Trading
-1.36% G/L:
$173.39 Last:
59,640 Volume:
$171.56 Open:
BLTE Latest News
BLTE Stock Data
$6,636,713,193
14,510,659
N/A
18
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
